Deep Genomics

Sector Biotechnology

Headquarters Toronto

Founder & CEO Brendan Frey

Founded 2015

Employees 101-250

Funding CAD $318.5M

In 2018, AI developed by Deep Genomics made a remarkable discovery. The model revealed the inner workings of a specific mutation that can lead to Wilson Disease – a rare inherited disorder that causes copper to accumulate in a body’s vital organs, with potentially fatal effects. Deep Genomics is now striving to correct genetic mutations and develop better treatments for individuals with rare diseases. CEO Brendan Frey founded Deep Genomics on the realization that “for the first time in history, medicine has become information.” And AI is simply more efficient at searching through it. The company’s work is powered by proprietary AI technology that is capable of understanding and swiftly navigating the vast and complex realms of human biology.